Evidence suggests that SOX2‐OT is involved in promoting/protecting the positive expression/translation of SOX2 in bladder carcinomas, where SOX2‐OT has been mainly identified in the cytoplasm. This evidence concerns the gene SOX2 and urinary bladder carcinoma.